{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:20:01Z","timestamp":1793056801148,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["82071963"],"award-info":[{"award-number":["82071963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the key medical and health projects in xiamen","award":["3502Z20191104"],"award-info":[{"award-number":["3502Z20191104"]}]},{"name":"the key medical and health projects in xiamen","award":["3502Z20209002"],"award-info":[{"award-number":["3502Z20209002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00259-021-05576-w","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T02:41:59Z","timestamp":1634265719000},"page":"1322-1337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Yizhen","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-8884","authenticated-orcid":false,"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"1","key":"5576_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551.","journal-title":"CA Cancer J Clin"},{"issue":"9414","key":"5576_CR2","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","volume":"363","author":"D Li","year":"2004","unstructured":"Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(04)15841-8.","journal-title":"Lancet"},{"key":"5576_CR3","unstructured":"NCCN Guidelines for Pancreatic Adenocarcinoma. Version 2.2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf. Accessed 25 Feb\u00a02021.\u00a0"},{"issue":"4","key":"5576_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrgastro.2013.42","volume":"10","author":"O Strobel","year":"2013","unstructured":"Strobel O, Buchler MW. Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis. Nat Rev Gastroenterol Hepatol. 2013;10(4):203\u20135. https:\/\/doi.org\/10.1038\/nrgastro.2013.42.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"5576_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.sla.0000172095.97787.84","volume":"242","author":"S Heinrich","year":"2005","unstructured":"Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, et al. Positron emission tomography\/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg. 2005;242(2):235\u201343. https:\/\/doi.org\/10.1097\/01.sla.0000172095.97787.84.","journal-title":"Ann Surg"},{"issue":"2","key":"5576_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2967\/jnmt.114.145458","volume":"43","author":"P Jha","year":"2015","unstructured":"Jha P, Bijan B. PET\/CT for pancreatic malignancy: potential and pitfalls. J Nucl Med Technol. 2015;43(2):92\u20137. https:\/\/doi.org\/10.2967\/jnmt.114.145458.","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"5576_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3748\/wjg.14.64","volume":"14","author":"H Wakabayashi","year":"2008","unstructured":"Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol. 2008;14(1):64\u20139. https:\/\/doi.org\/10.3748\/wjg.14.64.","journal-title":"World J Gastroenterol"},{"issue":"19","key":"5576_CR8","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3748\/wjg.v24.i19.2047","volume":"24","author":"L Zhang","year":"2018","unstructured":"Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24(19):2047\u201360. https:\/\/doi.org\/10.3748\/wjg.v24.i19.2047.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"5576_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00261-017-1374-2","volume":"43","author":"R Yeh","year":"2018","unstructured":"Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The role of 18F-FDG PET\/CT and PET\/MRI in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43(2):415\u201334. https:\/\/doi.org\/10.1007\/s00261-017-1374-2.","journal-title":"Abdom Radiol (NY)"},{"issue":"5\u20136","key":"5576_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8(5\u20136):454\u201363. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteomics Clin Appl"},{"issue":"9","key":"5576_CR11","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2967\/jnumed.118.214361","volume":"59","author":"JT Siveke","year":"2018","unstructured":"Siveke JT. Fibroblast-activating protein: targeting the roots of the tumor microenvironment. J Nucl Med. 2018;59(9):1412\u20134. https:\/\/doi.org\/10.2967\/jnumed.118.214361.","journal-title":"J Nucl Med"},{"issue":"6","key":"5576_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"issue":"8","key":"5576_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5576_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [(18)F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. 2021;48(1):73\u201386. https:\/\/doi.org\/10.1007\/s00259-020-04940-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"5576_CR15","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.3748\/wjg.v22.i9.2678","volume":"22","author":"MF Nielsen","year":"2016","unstructured":"Nielsen MF, Mortensen MB, Detlefsen S. Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells. World J Gastroenterol. 2016;22(9):2678\u2013700. https:\/\/doi.org\/10.3748\/wjg.v22.i9.2678.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"5576_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M Rohrich","year":"2021","unstructured":"Rohrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, et al. Impact of (68)Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med. 2021;62(6):779\u201386. https:\/\/doi.org\/10.2967\/jnumed.120.253062.","journal-title":"J Nucl Med"},{"issue":"5","key":"5576_CR17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00259-019-04654-4","volume":"47","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhuang Y, Fu K, Chen P, Wang Y, Zhuo J, et al. Usefulness of [(18)F]fluorodeoxyglucose PET\/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020;47(5):1065\u201374. https:\/\/doi.org\/10.1007\/s00259-019-04654-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5576_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MBES Amin","year":"2017","unstructured":"Amin MBES, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2017.","edition":"8"},{"key":"5576_CR19","doi-asserted-by":"publisher","unstructured":"Liermann J, Syed M, Ben-Josef E, Schubert K, Schlampp I, Sprengel SD et al. Impact of FAPI-PET\/CT on target volume definition in radiation therapy of locally recurrent pancreatic cancer. Cancers (Basel). 2021;13(4). https:\/\/doi.org\/10.3390\/cancers13040796.","DOI":"10.3390\/cancers13040796"},{"issue":"3","key":"5576_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/RLU.0000000000003491","volume":"46","author":"S Wu","year":"2021","unstructured":"Wu S, Pang Y, Chen Y, Sun H, Chen H. 68Ga-DOTA-FAPI-04 PET\/CT in Erdheim-Chester disease. Clin Nucl Med. 2021;46(3):258\u201360. https:\/\/doi.org\/10.1097\/RLU.0000000000003491.","journal-title":"Clin Nucl Med"},{"key":"5576_CR21","doi-asserted-by":"publisher","unstructured":"Wu S, Pang Y, Zhao L, Zhao L, Chen H. 68Ga-FAPI PET\/CT versus 18F-FDG PET\/CT for the evaluation of disease activity in Takayasu arteritis. Clin Nucl Med. 2021. https:\/\/doi.org\/10.1097\/RLU.0000000000003692","DOI":"10.1097\/RLU.0000000000003692"},{"key":"5576_CR22","doi-asserted-by":"publisher","unstructured":"Yao L, Zhao L, Pang Y, Shang Q, Chen H. Increased 68Ga-FAPI uptake in ankylosing spondylitis in a patient with rectal cancer. Clin Nucl Med. 2021. https:\/\/doi.org\/10.1097\/RLU.0000000000003798.","DOI":"10.1097\/RLU.0000000000003798"},{"key":"5576_CR23","doi-asserted-by":"publisher","unstructured":"Zhao L, Pang Y, Sun L, Lin Q, Chen H. Increased 68Ga-FAPI uptake in the pulmonary Cryptococcus and the postradiotherapy inflammation. Clin Nucl Med. 2021. https:\/\/doi.org\/10.1097\/RLU.0000000000003873.","DOI":"10.1097\/RLU.0000000000003873"},{"issue":"4","key":"5576_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RLU.0000000000002914","volume":"45","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan Q, Zhang W, Li F. Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in 68Ga-FAPI PET\/CT. Clin Nucl Med. 2020;45(4):310\u20131. https:\/\/doi.org\/10.1097\/RLU.0000000000002914.","journal-title":"Clin Nucl Med"},{"issue":"11","key":"5576_CR25","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","volume":"79","author":"C Schmidkonz","year":"2020","unstructured":"Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Gotz TI, Soare A, et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11):1485\u201391. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217408.","journal-title":"Ann Rheum Dis"},{"issue":"9976","key":"5576_CR26","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0.","journal-title":"Lancet"},{"key":"5576_CR27","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.2147\/IJN.S131295","volume":"12","author":"X Yu","year":"2017","unstructured":"Yu X, Zhu W, Di Y, Gu J, Guo Z, Li H, et al. Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases. Int J Nanomedicine. 2017;12:6771\u201385. https:\/\/doi.org\/10.2147\/IJN.S131295.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"5576_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1245\/s10434-013-3473-9","volume":"21","author":"MJ Kang","year":"2014","unstructured":"Kang MJ, Jang JY, Chang YR, Kwon W, Jung W, Kim SW. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage. Ann Surg Oncol. 2014;21(5):1545\u201351. https:\/\/doi.org\/10.1245\/s10434-013-3473-9.","journal-title":"Ann Surg Oncol"},{"key":"5576_CR29","doi-asserted-by":"publisher","unstructured":"Sahani DV, Bonaffini PA, Catalano OA, Guimaraes AR, Blake MA. State-of-the-art PET\/CT of the pancreas: current role and emerging indications. Radiographics. 2012;32(4):1133\u201358; discussion 58\u201360. https:\/\/doi.org\/10.1148\/rg.324115143.","DOI":"10.1148\/rg.324115143"},{"issue":"1","key":"5576_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.hpb.2019.05.015","volume":"22","author":"J Yang","year":"2020","unstructured":"Yang J, Zhang J, Lui W, Huo Y, Fu X, Yang M, et al. Patients with hepatic oligometastatic pancreatic body\/tail ductal adenocarcinoma may benefit from synchronous resection. HPB (Oxford). 2020;22(1):91\u2013101. https:\/\/doi.org\/10.1016\/j.hpb.2019.05.015.","journal-title":"HPB (Oxford)"},{"issue":"8\u20139","key":"5576_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.gcb.2009.04.014","volume":"34","author":"C Pery","year":"2010","unstructured":"Pery C, Meurette G, Ansquer C, Frampas E, Regenet N. Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions. Gastroenterol Clin Biol. 2010;34(8\u20139):465\u201374. https:\/\/doi.org\/10.1016\/j.gcb.2009.04.014.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"5576_CR32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1148\/rg.314105731","volume":"31","author":"G Low","year":"2011","unstructured":"Low G, Panu A, Millo N, Leen E. Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics. 2011;31(4):993\u20131015. https:\/\/doi.org\/10.1148\/rg.314105731.","journal-title":"Radiographics"},{"issue":"7","key":"5576_CR33","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1245\/s10434-009-0416-6","volume":"16","author":"DB Evans","year":"2009","unstructured":"Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16(7):1736\u201344. https:\/\/doi.org\/10.1245\/s10434-009-0416-6.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"5576_CR34","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48(6):1944\u201355. https:\/\/doi.org\/10.1007\/s00259-020-05146-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"5576_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00259-019-04552-9","volume":"47","author":"I Alberts","year":"2020","unstructured":"Alberts I, Sachpekidis C, Dijkstra L, Prenosil G, Gourni E, Boxler S, et al. The role of additional late PSMA-ligand PET\/CT in the differentiation between lymph node metastases and ganglia. Eur J Nucl Med Mol Imaging. 2020;47(3):642\u201351. https:\/\/doi.org\/10.1007\/s00259-019-04552-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"5576_CR36","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00259-020-05138-6","volume":"48","author":"R Mei","year":"2021","unstructured":"Mei R, Allegri V, Calabro D, Fanti S, Ambrosini V. Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET\/CT detection of primary duodenal neuroendocrine tumor (NET). Eur J Nucl Med Mol Imaging. 2021;48(5):1684\u20135. https:\/\/doi.org\/10.1007\/s00259-020-05138-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5576_CR37","doi-asserted-by":"publisher","unstructured":"Hoffmann MA, Buchholz HG, Wieler HJ, Rosar F, Miederer M, Fischer N et al. Dual-time point [(68)Ga]Ga-PSMA-11 PET\/CT hybrid imaging for staging and restaging of prostate cancer. Cancers (Basel). 2020;12(10). https:\/\/doi.org\/10.3390\/cancers12102788.","DOI":"10.3390\/cancers12102788"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05576-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-021-05576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T06:08:05Z","timestamp":1647238085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-021-05576-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5576"],"URL":"https:\/\/doi.org\/10.1007\/s00259-021-05576-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}